-
What it takes to supply COVID-19 vaccines across the globe — Novartis study: nurses and MS patients give thumbs-up to Kesimpta — Busy year ahead for Parkinson's Disease treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Latest News - ADU won't be approved
Discussion in 'BiogenIdec' started by anonymous, Oct 19, 2020 at 9:26 AM.
Tags:
Add Tags
Page 1 of 8
Page 1 of 8